TriSalus Life Sciences, Inc. (TLSIW) Total liabilities 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) total liabilities at each fiscal year-end, per SEC filings.
$69.2MFY2025 · since FY2022: $34.3M → $69.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $69.2M | +38.8% |
| FY2024 | $49.9M | -3.5% |
| FY2023 | $51.7M | +50.5% |
| FY2022 | $34.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Shareholders’ equityTLSIW overview →